The importance of cyclin D1-CDK4/6 in this process was exemplified in that RB null cells are refractory to the proliferative action of the cyclin D1-CDK4 complex, and RB deficient tumor cells often exhibit reduced cyclin D1 dependency [9,46-48]. This evidence concerns the gene CDK4 and neoplasm.